Core Viewpoint - A class action lawsuit has been filed against Concorde International Group, Ltd. for alleged violations of federal securities laws during the class period from April 21, 2025, to July 14, 2025, due to misleading statements and undisclosed adverse facts about the company's operations and securities trading activity [1][2][3]. Summary by Sections Lawsuit Details - The lawsuit seeks to recover damages for investors who purchased Concorde securities during the specified class period [2]. - Allegations include that Concorde was involved in a fraudulent stock promotion scheme utilizing social media misinformation and impersonation of financial professionals [3]. - It is claimed that insiders used offshore accounts to facilitate the dumping of shares during a price inflation campaign [3]. - The complaint states that Concorde's public statements omitted critical information regarding false rumors and artificial trading activity affecting stock prices [3]. Next Steps for Investors - Investors wishing to join the lawsuit must request to be appointed as lead plaintiff by May 18, 2026, although participation in any recovery does not require this role [4]. - A copy of the complaint can be reviewed on the law firm's website [4]. Legal Representation - Bronstein, Gewirtz & Grossman, LLC operates on a contingency fee basis, meaning they will only seek reimbursement for expenses and fees if successful in the lawsuit [5]. - The firm has a history of recovering significant amounts for investors in securities fraud cases [6].

Core Viewpoint - The Schall Law Firm is investigating claims against Chanson International Holding for potential violations of securities laws, focusing on whether the company made false or misleading statements or failed to disclose important information to investors [1][2]. Group 1: Investigation Details - The investigation is aimed at determining if Chanson International Holding issued false and/or misleading statements and/or failed to disclose pertinent information to investors [2]. - Investors who have suffered losses are encouraged to participate in the investigation [2]. Group 2: Legal Representation - The Schall Law Firm offers free consultations to discuss the rights of affected shareholders [3]. - The firm specializes in securities class action lawsuits and shareholder rights litigation, representing investors globally [3].

Core Viewpoint - The Schall Law Firm is reminding investors of a class action lawsuit against Concorde International Group Ltd. for alleged securities fraud, specifically violations of the Securities Exchange Act of 1934 [1][4]. Group 1: Lawsuit Details - The class action lawsuit pertains to investors who purchased Concorde's securities between April 21, 2025, and July 14, 2025 [2]. - The lawsuit claims that Concorde made false and misleading statements, and was involved in a fraudulent stock promotion scheme that inflated its share price [4]. Group 2: Investor Participation - Investors who suffered losses during the class period are encouraged to contact the Schall Law Firm before May 18, 2026, to participate in the lawsuit [2]. - The class has not yet been certified, meaning that until certification occurs, investors are not represented by an attorney [3].

Core Viewpoint - A class action lawsuit has been initiated against Concorde International Group Ltd. for securities fraud, with a call for investors who purchased shares between April 21, 2025, and July 14, 2025, to participate in the lawsuit [1][5]. Group 1: Lawsuit Details - The lawsuit alleges that during the Class Period, Concorde made false and misleading statements and failed to disclose critical information regarding a fraudulent stock promotion scheme and insider trading activities [5]. - Specific allegations include the use of social media misinformation, coordinated share dumping by insiders, and omissions of significant risks related to stock price manipulation [5]. Group 2: Participation Information - Investors who purchased Concorde securities during the Class Period may be eligible for compensation without incurring out-of-pocket costs through a contingency fee arrangement [2]. - Interested parties can join the class action by visiting the provided link or contacting the Rosen Law Firm directly [3][6].

Core Viewpoint - Nuvation Bio Inc. is under investigation by the Schall Law Firm for potential violations of securities laws, particularly regarding misleading statements and undisclosed information that may have affected investors [1][2]. Financial Performance - Nuvation reported its Q4 and full year 2025 financial results on March 2, 2026, revealing that a significant portion of early patient starts for its IBTROZI oncology therapy were in later-line treatment settings [2]. - The company disclosed that 75% of treatment discontinuations were from these later-line patient populations, which contributed to a gap between the number of patients starting IBTROZI and its net product revenue growth [2]. - Following this announcement, shares of Nuvation fell by 25.3% the next day [2]. Legal Context - The Schall Law Firm is encouraging shareholders who suffered losses to participate in the investigation and discuss their rights [3]. - The firm specializes in securities class action lawsuits and shareholder rights litigation, representing investors globally [3].

Core Viewpoint - The Schall Law Firm is investigating FS KKR Capital Corp. for potential violations of securities laws, particularly focusing on misleading statements and undisclosed information that may have affected investors [1][2]. Group 1: Investigation Details - The investigation centers on FS KKR Capital Corp.'s significant dividend cut announced on February 26, 2026, attributed to "specific challenges associated with a few investments" [2]. - Following the announcement of the dividend cut, shares of FS KKR Capital Corp. experienced a decline of over 18.9% the next day [2]. Group 2: Investor Participation - Shareholders who have suffered losses due to the company's actions are encouraged to participate in the investigation [2]. - The Schall Law Firm offers free consultations for investors to discuss their rights regarding the situation [3].

Core Viewpoint - The monday.com class action lawsuit alleges that the company and its executives made misleading statements regarding the company's financial outlook and growth potential, leading to significant stock price declines [1][4][5]. Group 1: Lawsuit Details - The lawsuit, titled Potter v. monday.com Ltd., seeks to represent purchasers of monday.com common stock and accuses the company of violating the Securities Exchange Act of 1934 [1]. - The allegations include that monday.com misrepresented its revenue outlook and growth prospects, particularly regarding new customer growth and enterprise sales cycles [4]. - The lawsuit claims that on February 9, 2026, monday.com announced it would no longer discuss its 2027 targets, resulting in a nearly 21% drop in stock price [5]. Group 2: Lead Plaintiff Process - Investors who purchased monday.com common stock during the class period can seek to be appointed as lead plaintiff, representing the interests of the class [6]. - The lead plaintiff is typically the investor with the greatest financial interest in the case and can select a law firm to litigate on behalf of the class [6]. Group 3: About Robbins Geller - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder rights litigation, having recovered over $916 million for investors in 2025 alone [7]. - The firm has a strong track record, recovering a total of $8.4 billion for investors over the past five years, making it one of the largest plaintiffs' firms globally [7].

Core Viewpoint - The lawsuit against BellRing Brands, Inc. alleges that the company and its executives misled investors regarding the true drivers of its sales growth, which was primarily due to retailers hoarding inventory rather than genuine consumer demand [3][5]. Company Overview - BellRing Brands, Inc. is facing a securities fraud lawsuit that claims misleading statements were made about the sustainability and drivers of its sales growth, as well as the competitive landscape affecting demand for its products [5][6]. Allegations of Misleading Information - The lawsuit contends that BellRing's reported sales growth in 2025 was artificially inflated due to retailers stockpiling inventory to prevent shortages, rather than reflecting actual consumer demand [3][7]. - A significant drop in BellRing's share price occurred after disclosures revealed that retailers were reducing their inventory levels, leading to a 33% decline in share price on August 4, 2025 [3][7]. Financial Impact - Following the revelation of disappointing financial results for Q2 2025, BellRing's CFO admitted that some retailers had been hoarding inventory, which contributed to a 19% drop in share price [7]. - The Q3 2025 financial results further indicated a narrowed sales outlook, resulting in a 33% drop in share price, as analysts expressed skepticism about the company's consumption levels compared to shipments [7]. Legal Proceedings - The lead plaintiff deadline for the lawsuit is set for March 23, 2026, and investors who suffered losses from purchasing BellRing shares between November 19, 2024, and August 4, 2025, are encouraged to participate [6][7].

Core Viewpoint - A securities fraud class action lawsuit has been filed against NuScale Power Corporation, alleging that the company made false statements regarding its commercialization strategy and the experience of its partner, ENTRA1 Energy LLC, during the class period from May 13, 2025, to November 6, 2025 [1][2][3]. Group 1: Lawsuit Details - The lawsuit is filed in the United States District Court for the District of Oregon, under the case caption Truedson v. NuScale Power Corporation, et al, Case No. 3:26-cv-00328 (D. Or.) [1]. - Investors have until April 20, 2026, to file for lead plaintiff status [1][3]. - The complaint alleges that NuScale misrepresented ENTRA1's capabilities, claiming it had experience in nuclear power generation, which it did not possess [2][3]. Group 2: Financial Impact - On November 6, 2025, NuScale reported a significant increase in general and administrative expenses, which rose over 3,000% to $519 million from $17 million in the prior year period, primarily due to a payment of $495 million to ENTRA1 [3][5]. - As a result of these financial disclosures, NuScale's quarterly net loss increased to $532 million, up from $46 million in the previous year [5]. - Following this announcement, NuScale's stock price dropped by $5.45 per share, or approximately 14.4%, closing at $32.46 on November 6, 2025, down from $37.91 the previous day [5].

Core Viewpoint - A securities fraud class action lawsuit has been filed against Trip.com Group Limited (NASDAQ: TCOM) for allegedly making materially false and misleading statements regarding its business operations and regulatory risks during the class period from April 30, 2024, to January 13, 2026 [2][4][7]. Group 1: Lawsuit Details - The lawsuit is filed in the United States District Court for the Eastern District of New York, under the case caption De Wilde v. Trip.com Group Limited, et al, Case No. 1:26-cv-01420 (E.D.N.Y.) [2][4]. - Investors have until May 11, 2026, to file for lead plaintiff status [2][7]. Group 2: Allegations - The complaint alleges that Trip.com failed to disclose significant regulatory risks associated with its monopolistic business practices, which misled investors about the company's true operational status [4]. - The lawsuit claims that positive statements made by the defendants regarding the company's business and prospects lacked a reasonable basis [4]. Group 3: Stock Price Impact - Following a Bloomberg article on January 14, 2026, which reported that China is investigating Trip.com for alleged antitrust conduct, the company's stock price dropped by $12.90 per share, approximately 17.05%, closing at $62.78 per share [5]. Group 4: Investor Actions - Investors who purchased Trip.com securities and incurred losses are encouraged to contact Kessler Topaz Meltzer & Check, LLP for potential recovery options at no cost [3][7]. - The lead plaintiff process allows investors to seek representation in the lawsuit, with the deadline for filing set for May 11, 2026 [9].